<DOC>
	<DOCNO>NCT01001247</DOCNO>
	<brief_summary>The purpose study investigate extent intake 20 mg daily ( q.d . ) omeprazole influence level TMC278 blood intake 25 mg q.d.. This study also investigate - case level TMC278 reduce co-administered omeprazole - whether double dose TMC278 ( 50 mg q.d . ) separation intake drug 12 hour may circumvent decrease TMC278 level blood clinical effective concentration . Omeprazole prescribed reduce production gastric acid . Since TMC278 require gastric acid properly dissolve take blood circulation , intake omeprazole influence level TMC278 blood circulation . This effect reveal previously conduct clinical trial , use combination 150 mg TMC278 q.d . 20 mg q.d . omeprazole . The currently propose study also explore relationship level TMC278 blood several time point acidity stomach . Also short-term safety tolerability co-administration omeprazole 20 mg q.d . TMC278 25 mg q.d . assess .</brief_summary>
	<brief_title>TMC278-TiDP6-C154 : Evaluation Possible Influence Omeprazole Intake - pH Increase Stomach Triggered Omeprazole Intake - Blood Levels TMC278 Healthy Volunteers</brief_title>
	<detailed_description>This open label study , mean party include study doctor , healthy volunteer sponsor plus designees know time treatment volunteer . This 4-way cross trial , mean every volunteer sequentially subject 4 different treatments.There 4 treatment sequence define : ABCD , BDAC , CADB DCBA . Treatment session organize way successive intake TMC278 period 14 day respect . Treatment A reference , show level TMC278 blood without intake omeprazole . These data point compare blood level TMC278 TMC278 administer 1.5 hour intake omeprazole ( Treatment B ) blood level TMC278 administer 12 hour intake omeprazole ( Treatment C ) . Treatment B comparator Treatment D , order reveal whether double dose TMC278 ( 50 mg q.d . use Treatment D ) circumvent reduction TMC278 level co-administered omeprazole , applicable . In session , extensive investigation level TMC278 blood circulation plan . Levels TMC278 assess 16 different time point , i.e . administration TMC278 , 0.5 , 1 , 2 , 3 , 4 , 5 , 6 , 9 , 12 , 16 , 24 , 48 , 72 , 120 168 hour intake TMC278 . During treatment , acidity stomach ( call intragastric pH ) monitor 24-hour period day TMC278 intake . Standard Safety assessment ( blood biochemistry haematology , urine analysis , ECG , pulse rate blood pressure ) perform Day1 , 2 8 Treatment A Day-5 , 1 , 2 , 8 Treatment B , C D. Treatment A : 25mg TMC278 morning Day1 ; Treatment B : 25mg TMC278 morning Day1 20mg omeprazole morning Day-5 Day2 ( 7 day total ) ; Treatment C : treatment B , omeprazole take evening ; Treatment D : treatment B , 50mg omeprazole take instead 25mg . All intakes oral . In Treatment B , C D , intake omeprazole witness site staff Days -5 , -3 , -2 -1</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Rilpivirine</mesh_term>
	<criteria>Smoking 10 cigarette , 2 cigar , 2 pipe per day ( nonsmoking ) least 3 month prior selection Weight define Body Mass Index ( BMI , weight kg divide square height meter ) 18.0 30.0 kg/m2 , extremes include Informed Consent Form ( ICF ) sign voluntarily Able comply protocol requirement Healthy basis pretrial physical examination , medical history , result blood biochemistry hematology test , urinalysis , vital sign , 12lead electrocardiogram ( ECG ) No positive test HIV1 2 female , except menopausal least 2 year , total hysterectomy bilateral tubal ligation ( without repair surgery ) No infection Hepatitis A , B C No currently active gastrointestinal , cardiovascular , neurologic , psychiatric , metabolic , renal , hepatic , respiratory , inflammatory infectious disease No history clinically relevant heart rhythm disturbances No positive urine drug test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>TMC278-TiDP6-C154</keyword>
	<keyword>TMC278-C154</keyword>
	<keyword>TMC278</keyword>
	<keyword>Healthy volunteer</keyword>
	<keyword>omeprazole</keyword>
	<keyword>proton pump inhibitor</keyword>
	<keyword>HIV</keyword>
</DOC>